JAEGER RAVEN 4
4 · Diffusion Pharmaceuticals Inc. · Filed Aug 26, 2022
Insider Transaction Report
Form 4
JAEGER RAVEN
Chief Regulatory Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+8,000→ 8,000 totalExercise: $7.75Exp: 2032-06-07→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 36-month period beginning June 30, 2022.